ArticleHeliyon2024

Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort.

Alessandro Soria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.